Seres Therapeutics, Inc.
MCRB
$4.54
$0.061.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -126.13% | -164.29% | 4,088.24% | 121.17% | 153.03% |
| Total Depreciation and Amortization | -14.29% | -13.73% | -14.56% | -9.73% | -9.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -73.57% |
| Total Other Non-Cash Items | 113.70% | 109.23% | 110.74% | 110.72% | -502.10% |
| Change in Net Operating Assets | -10.67% | 74.56% | 57.59% | -3.17% | 21.32% |
| Cash from Operations | 14.49% | 51.25% | 100.75% | 85.34% | 67.03% |
| Capital Expenditure | 91.47% | 38.07% | 33.68% | 73.18% | 84.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Investing | -99.87% | -100.01% | -100.03% | -100.22% | 9,921.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -25.51% | -34.11% | -62.97% | -92.95% | -25.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 113.77% | 112.18% | 115.38% | 103.48% | -505.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.82% | 44.31% | 115.49% | 79.89% | 82.72% |